Advanced company searchLink opens in new window

ENVISION PHARMA HOLDCO LIMITED

Company number 08555733

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 Sep 2024 AA Audit exemption subsidiary accounts made up to 31 December 2023
10 Sep 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/23
10 Sep 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/23
10 Sep 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/23
14 Jun 2024 CS01 Confirmation statement made on 2 June 2024 with no updates
07 Jun 2024 PSC05 Change of details for a person with significant control
27 Sep 2023 AP01 Appointment of Mr Howard Collins Miller Iii as a director on 12 September 2023
26 Sep 2023 TM01 Termination of appointment of Margaret Heim as a director on 2 August 2023
26 Sep 2023 AA Audit exemption subsidiary accounts made up to 31 December 2022
26 Sep 2023 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/22
26 Sep 2023 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/22
26 Sep 2023 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/22
13 Jun 2023 CS01 Confirmation statement made on 2 June 2023 with updates
22 Mar 2023 AP01 Appointment of Mrs Margaret Heim as a director on 21 February 2023
17 Mar 2023 RP04CS01 Second filing of Confirmation Statement dated 6 June 2018
17 Mar 2023 RP04CS01 Second filing of Confirmation Statement dated 2 June 2021
17 Mar 2023 RP04CS01 Second filing of Confirmation Statement dated 2 June 2020
17 Mar 2023 RP04CS01 Second filing of Confirmation Statement dated 2 June 2017
17 Mar 2023 RP04CS01 Second filing of Confirmation Statement dated 9 June 2019
17 Mar 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 29 May 2019
  • USD 4,554,171.41
22 Feb 2023 SH01 Statement of capital following an allotment of shares on 6 February 2023
  • USD 4,554,171.41
22 Sep 2022 AA Audit exemption subsidiary accounts made up to 31 December 2021
22 Sep 2022 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/21
22 Sep 2022 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/21
22 Sep 2022 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/21